Literature DB >> 2986260

Adenosine formation. Evidence for a direct biochemical link with energy metabolism.

A C Newby, Y Worku, C A Holmquist.   

Abstract

The increase in tissue and coronary effluent adenosine concentration in hearts undergoing net ATP breakdown results from an accelation of adenosine formation and not from an inhibition of adenosine inactivation. Adenosine formation takes place inside intact isolated cells by a pathway distinct from the cell membrane 5'-nucleotidase, which hydrolyzes only extracellular AMP. Both the magnitude and the variation in the rate of adenosine formation in polymorphonuclear leukocytes undergoing ATP catabolism can be accounted for by the properties of a cytosolic 5'-nucleotidase that is also present in heart. This enzyme, which is allosterically activated by ATP-Mg and inhibited by Pi, provides a direct biochemical link between the energy status of the cell and the rate of adenosine formation. The actions of adenosine to dilate coronary arterioles, antagonize the inotropic effect of catecholamines, and reduce sympathetic-nerve firing would ameliorate the original energy imbalance. Adenosine may therefore function in heart and also in brain, skeletal muscle, kidney, and adipose tissue as a "retaliatory metabolite" that protects the cell against excessive external stimulation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986260

Source DB:  PubMed          Journal:  Adv Myocardiol        ISSN: 0270-4056


  27 in total

1.  Purines and the Anti-Epileptic Actions of Ketogenic Diets.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin; Jeremy Gawryluk; Xuesong Chen; Jonathan D Geiger
Journal:  Open Neurosci J       Date:  2010-01-01

2.  Cell and gene therapies for refractory epilepsy.

Authors:  Detlev Boison
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

Review 3.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

Review 4.  Purines and neuronal excitability: links to the ketogenic diet.

Authors:  S A Masino; M Kawamura; D N Ruskin; J D Geiger; D Boison
Journal:  Epilepsy Res       Date:  2011-08-30       Impact factor: 3.045

5.  Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia.

Authors:  Cassidy L Moody; Adam J Funk; Emily Devine; Ryan C Devore Homan; Detlev Boison; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

Review 6.  Adenosine dysfunction in epilepsy.

Authors:  Detlev Boison
Journal:  Glia       Date:  2011-12-22       Impact factor: 7.452

Review 7.  Adenosine and Ketogenic Treatments.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  J Caffeine Adenosine Res       Date:  2020-09-16

Review 8.  Regulation of adenosine levels during cerebral ischemia.

Authors:  Stephanie Chu; Wei Xiong; Dali Zhang; Hanifi Soylu; Chao Sun; Benedict C Albensi; Fiona E Parkinson
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

Review 9.  Adenosine--a physiological or pathophysiological agent?

Authors:  Bertil B Fredholm
Journal:  J Mol Med (Berl)       Date:  2013-12-22       Impact factor: 4.599

Review 10.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.